Diseased cartilage harbors unique migratory progenitor cells

Apr 02, 2009

A new study finds previously unidentified fibrocartilage-forming progenitor cells in degenerating, diseased human cartilage, but not in cartilage from healthy joints. The research, published by Cell Press in the April 3rd issue of the journal Cell Stem Cell, provides valuable insights into the reparative potential of cartilage and may lead to development of regenerative therapies for arthritis.

Osteoarthritis (OA) is an incurable degenerative disease caused by a progressive deterioration of the cartilage that cushions and protects joints. "OA is the most common musculoskeletal disease in the elderly and is likely to be the fourth-leading cause of disability by the year 2020," explains senior study author Dr. Nicolai Miosge from Georg August University in Goettingen, Germany. "This is our motivation for the further exploration of OA treatment options, including regenerative cell biological therapy."

Previous research has suggested that OA tissue may harbor cells which possess an ability to contribute to the repair of damaged cartilage. It has even been suggested that these potentially regenerative cells may be specifically recruited to degenerating cartilage. In their study, Dr. Miosge and colleagues sought to determine whether diseased adult cartilage tissue contains progenitor-like cells that exhibit migratory capabilities.

The researchers discovered that cartilage from humans with late-stage OA contains a unique population of called chondrogenic progenitor cells (CPC). The CPCs, which were not present in healthy cartilage, exhibited many characteristics associated with tissue-specific , including migratory activity and the potential to generate new cartilage. Although the origin of the CPCs was not clear, there was some evidence that they migrated from the .

Taken together, the findings establish CPCs as an exciting future target for stimulating the repair and regeneration of damaged cartilage. "Our results offer new insights into the biology of progenitor cells in the context of diseased cartilage tissue," offers Dr. Miosge. "We hope ultimately to work towards utilizing these cells—which are already present in diseased tissue—for the development of regenerative OA therapies." Additional research is needed to identify the optimal conditions for promoting and sustaining the cartilage-producing potential of CPCs.

Source: Cell Press (news : web)

Explore further: Boosting armor for nuclear-waste eating microbes

add to favorites email to friend print save as pdf

Related Stories

Embryonic stem cells used to grow cartilage

Sep 06, 2007

Rice University biomedical engineers have developed a new technique for growing cartilage from human embryonic stem cells, a method that could be used to grow replacement cartilage for the surgical repair of knee, jaw, hip, ...

Stems cells might help repair joints

Feb 07, 2007

U.S. scientists have built a unique weaving machine that creates a three-dimensional fabric "scaffold" to repair joints with a patient's own stem cells.

New test to diagnose osteoarthritis early

Aug 20, 2008

A newly developed medical imaging technology may provide doctors with a long-awaited test for early diagnosis of osteoarthritis (OA), scientists from New York reported today at the 236th National Meeting of the American Chemical ...

Recommended for you

Unraveling cell division

9 minutes ago

CRG researchers shed new light on mitosis. The study published in the Journal of Cell Biology describes how Topo 2 disentangles DNA molecules and is essential for proper cell division

Think big: Bacteria breach cell division size limit

22 hours ago

The life of a cell is straightforward: it doubles, divides in the middle and originates two identical daughter cells. Therefore, it has been long assumed that cells of the same kind are similarly sized and ...

User comments : 1

Adjust slider to filter visible comments by rank

Display comments: newest first

bredmond
not rated yet Apr 06, 2009
This is some relief. I feel that most of the stem cell marketing is too focused on diseases like diabetes, and parkenson's. I dont mean to diminish those diseases, but many people suffer from diseases in connective tissue and i never see any consideration given for those diseases. All the sports related diseases, the elderly, and just accidents in general. they would probably feel enormous relief from healing those wounds.